Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice

New FDA Regulation to Improve Safety Reporting in Clinical Trials

(2011) Rachel Behrman Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Collaborative Clinical Trials

(2011) Arthur J. Moss et al.   NEW ENGLAND JOURNAL OF MEDICINE

The ClinicalTrials.gov Results Database — Update and Key Issues

(2011) Deborah A. Zarin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

The importance of independent academic statistical analysis

(2010) C. D. Deangelis et al.   BIOSTATISTICS

Revisiting the Rosiglitazone Story — Lessons Learned

(2010) Clifford J. Rosen   NEW ENGLAND JOURNAL OF MEDICINE

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Determining the most appropriate components for a composite clinical trial outcome

(2008) M. Angelyn Bethel et al.   AMERICAN HEART JOURNAL

Industry-Sponsored Clinical Research

(2008) Marcia Angell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION